Managers / Q4 2023 · view latest →
HARBOURVEST PARTNERS LLC
CIK 0001201001 · ONE LINCOLN STREET, SUITE 1700, BOSTON, MA, 02111 · 617-348-3707
Reported Value
$299M
Q4 2023
Positions
53
Filings on Record
32
2019–present window
Filed
Feb 14, 2024
original filing
Summary
Harbourvest Partners LLC reported $299M in U.S.-listed holdings across 53 positions for Q4 2023.
The portfolio is heavily concentrated: W alone accounts for 22.0% of reported value.
Compared with Q3 2023, the fund opened 2 new positions and exited 7.
Portfolio Metrics
Turnover
+18.3%
vs prior filed quarter
Top-10 Concentration
+82.5%
share of reported value
Largest Position
+22.0%
Wayfair
New / Exited
2 / 7
positions this quarter
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 75.2% · $225M
- Other · 20.7% · $62M
- ADR · 4.1% · $12M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| COINCoinbase Global Inc. | NEW | +157.2K | 157.2K | +$27M | $27M |
| Crescent Point Corp. | NEW | +1.68M | 1.68M | +$12M | $12M |
| Solarwinds Corp. | SOLD OUT | −3.11M | 0 | −$29M | $0 |
| Hammerhead Energy Inc. | SOLD OUT | −607.3K | 0 | −$7M | $0 |
| EVLOEvelo Biosciences, Inc. | SOLD OUT | −1.45M | 0 | −$6M | $0 |
| CXMSprinklr, Inc | SOLD OUT | −220.5K | 0 | −$3M | $0 |
| Axcella Health, Inc. | SOLD OUT | −248.3K | 0 | −$3M | $0 |
| FTCHQFarfetch Ltd. | SOLD OUT | −442.7K | 0 | −$925,276 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2023
50 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | WWayfair Inc.history → | Common CLA | 21.95% | $66M | 1.06M |
| 2 | TOSTToast, Inc.history → | Common CLA | 13.96% | $42M | 2.28M |
| 3 | NABLN-Able, Inc.history → | Common | 12.88% | $38M | 2.90M |
| 4 | Monday.com | SHS | 11.45% | $34M | 182.0K |
| 5 | COINCoinbase Global Inc.history → | Common CLA | 9.16% | $27M | 157.2K |
| 6 | Crescent Point Corp. | Common | 3.89% | $12M | 1.68M |
| 7 | Omega Therapeutics, Inc. | Common | 3.54% | $11M | 3.51M |
| 8 | YMMFull Truck Alliance Co. Ltd.history → | Sponsored ADS | 2.25% | $7M | 957.6K |
| 9 | HSAIHesai Grouphistory → | Sponsored ADS | 1.81% | $5M | 606.1K |
| 10 | HCP2EURHashiCorp, Inc.history → | Common CLA | 1.66% | $5M | 209.3K |
| 11 | LCEURLendingClub Corp.history → | Common | 1.50% | $4M | 513.4K |
| 12 | PGNYProgyny, Inc.history → | Common | 1.12% | $3M | 89.7K |
| 13 | RLAYRelay Therapeutics, Inc.history → | Common | 1.09% | $3M | 296.4K |
| 14 | Spotify Technology S.A. | SHS | 1.06% | $3M | 16.8K |
| 15 | Inari Medical | Common | 0.84% | $3M | 38.5K |
| 16 | BEBloom Energy Corporation | Common CLA | 0.80% | $2M | 162.2K |
| 17 | ACVAACV Auctions, Inc. | Common CLA | 0.75% | $2M | 147.1K |
| 18 | COURCoursera, Inc. | Common | 0.69% | $2M | 106.1K |
| 19 | OLOGBXOlo, Inc. | Common CLA | 0.65% | $2M | 341.8K |
| 20 | AMPLAmplitude Inc. | Common CLA | 0.65% | $2M | 153.0K |
| 21 | Jfrog Ltd. | ORD SHS | 0.63% | $2M | 54.0K |
| 22 | IBRXImmunityBio, Inc. | Common | 0.56% | $2M | 335.7K |
| 23 | DOCNDigital Ocean, Inc. | Common | 0.54% | $2M | 44.2K |
| 24 | PATHUiPath, Inc. | Common CLA | 0.53% | $2M | 63.7K |
| 25 | HNSTThe Honest Company Inc. | Common | 0.53% | $2M | 475.6K |
| 26 | ZUOUSDZuora, Inc. | Common | 0.52% | $2M | 163.9K |
| 27 | UUnity Software | Common | 0.47% | $1M | 34.2K |
| 28 | DOCSDoximity, Inc. | Common CLA | 0.47% | $1M | 49.8K |
| 29 | IASIntegral Ad Science, Inc. | Common | 0.44% | $1M | 91.8K |
| 30 | AFRMAffirm, Inc. | Common CLA | 0.38% | $1M | 23.2K |
| 31 | TWLOTwilio, Inc. | Common CLA | 0.37% | $1M | 14.6K |
| 32 | DIBS1stdibs.com, Inc. | Common | 0.31% | $933,641 | 199.5K |
| 33 | PLRXPliant Therapeutics, Inc. | Common | 0.30% | $895,250 | 49.4K |
| 34 | EB4Eventbrite, Inc. | Common CLA | 0.29% | $854,091 | 102.2K |
| 35 | PINSPinterest, Inc. | Common CLA | 0.26% | $789,322 | 21.3K |
| 36 | SONDQSonder Holdings, Inc. | CL A NEW | 0.26% | $763,130 | 225.1K |
| 37 | GTMZoom Information, Inc | Common | 0.24% | $715,434 | 38.7K |
| 38 | HOODRobinhood Markets Inc. | Common CLA | 0.22% | $645,727 | 50.7K |
| 39 | QSQuantumScape Corporation | Common CLA | 0.18% | $548,376 | 78.9K |
| 40 | SANASana Biotechnology, Inc. | Common | 0.16% | $480,192 | 117.7K |
| 41 | CPNGCoupang Inc. | Common CLA | 0.15% | $434,442 | 26.8K |
| 42 | Bright Health Group, Inc. | Common | 0.13% | $402,254 | 52.7K |
| 43 | DASHDoorDash, Inc. | Common CLA | 0.08% | $247,719 | 2.5K |
| 44 | PACBPacific Biosciences of California, Inc. | Common | 0.08% | $230,378 | 23.5K |
| 45 | OPENOpendoor Technologies Inc. | Common | 0.07% | $209,247 | 46.7K |
| 46 | IPSCCentury Therapeutics, Inc. | Common | 0.03% | $96,340 | 29.0K |
| 47 | RPTXRepare Therapeutics, Inc. | Common | 0.03% | $89,615 | 12.3K |
| 48 | MCRB1EURSeres Therapeutics, Inc. | Common | 0.02% | $69,108 | 49.4K |
| 49 | Rallybio Holdings, LLC | Common | 0.02% | $52,286 | 21.9K |
| 50 | PMVPPMV Pharmaceuticals | Common | 0.01% | $35,752 | 11.5K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $101M | 5 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $174M | 7 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $205M | 9 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $91M | 15 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $154M | 16 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $203M | 22 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $192M | 34 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $188M | 40 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $219M | 48 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $299M | 53 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $295M | 58 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $352M | 60 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $297M | 63 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $299M | 65 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $306M | 67 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $305M | 62 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $490M | 66 | May 26, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2021 | $782M | 67 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.1B | 56 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.0B | 51 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $746M | 44 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $256M | 26 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $270M | 36 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $232M | 28 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $207M | 36 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $243M | 35 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $240M | 33 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $262M | 32 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $283M | 33 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $211M | 32 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.